
Laura Ingraham @IngrahamAngle
“Although this retrospective study was performed w/ the critically ill COVID-19 patients, hydroxychloroquine should also be an option for early stage of patients because the safety records and their long history of use in treating malaria” https://t.co/D3P64FSC99 — PolitiTweet.org